The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.53
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (6.897%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.53
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: UBS down 15%, Credit Suisse down 60% after deal

Mon, 20th Mar 2023 08:53

(Alliance News) - Stock prices in London opened lower on Monday morning as the emergency takeover of beleaguered lender Credit Suisse over the weekend failed to quell market turmoil.

"It is not yet known exactly where more pain will emerge in the banking sector, but investors fear the problems are not yet over," said Susannah Streeter, head of money and markets at Hargreaves Lansdown.

The FTSE 100 index opened down 115.03 points, 1.6%, at 7,220.37. The FTSE 250 was down 405.08 points, or 2.2%, at 18,065.75, and the AIM All-Share was down 9.52 points, or 1.2%, at 794.51.

The Cboe UK 100 was down 1.5% at 722.97, the Cboe UK 250 was down 2.1% at 15,697.40, and the Cboe Small Companies was down 1.6% at 12,644.51.

UBS will take over its troubled Swiss rival Credit Suisse for USD3.25 billion following crunch talks on Sunday aimed at stopping the stricken bank from triggering a wider international banking crisis.

The Swiss government said the deal, involving Switzerland's biggest bank taking over the second-largest, was vital to prevent irreparable economic turmoil spreading throughout the country and beyond.

Michael Hewson, chief market analyst at CMC Markets, said: "Some have suggested that UBS putting such a low-ball number on its interest means that Credit Suisse could be in more trouble than perhaps regulators are letting on, and while that might be true, it could also be UBS management being extremely cautious."

Shares in UBS were 15% lower in Zurich on Monday morning. The bank has a market capitalisation of CHF53.17 billion. Shares in Credit Suisse plunged 63% for a market cap of just CHF2.78 billion, about USD2.99 billion.

The acquisition was welcomed in Washington, Brussels and London as one that would support financial stability.

The Bank of England has insisted the financial system in the UK remains "safe and sound", in an effort to calm fears after the emergency sale.

The pound was quoted at USD1.2170 at early on Monday in London, virtually unchanged compared to USD1.2168 at the London equities close on Friday.

In European equities on Monday, the CAC 40 in Paris was down 0.8%, while the DAX 40 in Frankfurt was down 1.0%.

France's central bank chief sought to distance European and French banks from the problems at Credit Suisse and banking woes in the US.

Credit Suisse and the banking volatility in the US "don't concern French and European banks", Francois Villeroy de Galhau, a member of the European Central Bank's governing council, told France Inter radio.

The euro stood at USD1.0636, lower from USD1.0665 late Friday. Against the yen, the dollar was trading at JPY130.69, down from JPY132.12.

Francesco Pesole at ING said he expects the yen to stay in demand for now amid the current risk-off market backdrop.

The US Federal Reserve and other major central banks are making a coordinated effort to improve banks' access to liquidity. The special drive will be launched on Monday by the Fed and the central banks of Canada, the UK, Japan, the EU and Switzerland.

The move comes after the US banking regulator struck a deal to sell most of the assets of the failed Signature Bank to another institution on Sunday.

Signature Bank was seized by the Federal Deposit Insurance Corp a week ago after it imploded in the wake of the collapse of Silicon Valley Bank earlier in March. The FDIC is seeking a similar deal to sell off parts of SVB, according to Bloomberg.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "The next few hours of trading will give us a better picture on whether the crisis is contained."

In London, banking stocks were the worst performers in early morning trade. Barclays was down 7.4%, Standard Chartered down 8.0%, NatWest down 7.8%, and Lloyds down 4.6%. HSBC, which last week bought the UK arm of SVB, was 5.1% lower.

Conversely, mining stocks were some of Monday's top performers, with Fresnillo up 3.3% and Endeavour Mining up 6.2%.

Separately, the UK water services regulation authority Ofwat on Monday announced new powers that will enable it to stop the payment of dividends by water utilities if they would "risk the company's financial resilience". It said it would also take enforcement action against water companies that don't link dividend payments to performance.

Ofwat said the change will require company board to "take account of their performance" for customers and the environment when deciding to make dividend payments and will require companies to "maintain a higher level of overall financial health".

Water utilities were higher in early morning trade, with investors perhaps fearing worse from the regulator amid growing political pressure following the repeated release of sewage into UK rivers. United Utilities was up 1.2%, Severn Trent up 1.3%, and Pennon up 0.3%.

Elsewhere in the FTSE 100, Intertek was down 0.4%. The product testing, inspecting and certification firm announced the promotion of Colm Deasy to chief financial officer.

Deasy replaces Jonathan Timmis who has stepped down with immediate effect, with no reason provided by the company for his departure.

In the FTSE 250, FirstGroup fell 1.4% despite announcing it extended the current arrangements for its West Coast partnership rail contract with the UK Department for Transport.

The arrangements were set to expire on March 31 and have now been extended to October 15, "broadly" under the same terms and conditions, the public transport provider said.

The contract comprises of the operation of Avanti West Coast and the shadow operation of the HS2 programme.

On AIM, Genedrive jumped 8.1% after it announced that its MT-RNR1 ID kit is in process for roll out at two further hospital sites in the Greater Manchester.

Genedrive's MT-RNR1 ID kit is a commercial point-of-care genetic test that helps to avoid irreversible lifelong hearing loss in specific infants exposed to aminoglycosides antibiotics by detecting a gene variant that can cause deafness, allowing for alternative antibiotics to be prescribed.

In Asia on Monday, the Japanese Nikkei 225 index closed down 1.4%. In China, the Shanghai Composite closed down 0.5%, while the Hang Seng index in Hong Kong finished down 2.7%. The S&P/ASX 200 in Sydney lost 1.4%.

China's central bank left its interest rates unchanged. The People's Bank of China said it held its one-year loan prime rate - which serves as a benchmark for corporate loans - at 3.65%. The five-year rate also remained at 4.3%.

It was the seventh successive month that the PBoC left rates unchanged. The move had been anticipated by the market, according to FXStreet-cited consensus.

In the US on Friday, Wall Street ended lower, with the Dow Jones Industrial Average down 1.2%, the S&P 500 down 1.1% and the Nasdaq Composite down 0.7%.

Brent oil was quoted at USD70.26 a barrel early in London on Monday, down from USD73.43 late Friday. Gold was quoted at USD2,004.05 an ounce, sharply higher against USD1,957.76.

Naeem Aslam, chief investment officer at Zaye Capital Markets, said the yellow metal remains in demand because investors believe that banks are not out of the woods yet.

"Traders always prefer safe haven in a situation like this as the contagion risk is always very high," Aslam said.

Still to come in Monday's economic calendar, there is a US retail trade report at 1400 GMT.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

Read more
3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Read more
3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

Read more
9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

Read more
28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

Read more
28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Read more
15 Jan 2019 12:44

Genedrive Interim Revenue Rises On US And UK Government Contracts

LONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end

Read more
15 Jan 2019 10:17

Genedrive makes progress with HCV kit in first half

(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.

Read more
10 Dec 2018 16:23

BGF Investment Management Now Owns 12.8% Stake In Genedrive (ALLISS)

LONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,

Read more
29 Nov 2018 13:56

Genedrive To Participate In Study For Use Of HCV Assay In Pharmacies

LONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus

Read more
29 Nov 2018 11:49

Genedrive to participate in three-country HCV therapy study

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Thursday that it will participate in an international multicentre trial, designed to assess the impact of outreach HCV diagnostics and therapy in a pharmacy setting when compared conventional treatment pathways.

Read more
22 Aug 2018 11:17

Genedrive Appoints Chris Yates As Non-Executive Director

LONDON (Alliance News) - Diagnostics company Genedrive PLC said Wednesday it appointed Chris Yates as non-executive director with immediate effect.Yates has been Chief Executive Officer of

Read more
8 Aug 2018 12:05

Genedrive Partners With FIND To Evaluate Its Hepatitis C Virus Kit

LONDON (Alliance News) - Genedrive PLC said Wednesday it partnered with the Foundation for Innovation of New Diagnostics, or FIND, which will evaluate its hepatitis C virus kit.The kit is a

Read more
20 Jun 2018 09:57

Genedrive Given Grant For NHS Point-Of-Care Test Development

LONDON (Alliance News) - Genedrive PLC's said Wednesday it was awarded a multi-partner grant to develop a pharmacogenetic test to fight antibiotic-related hearing loss in newborn molecular was

Read more
14 May 2018 18:07

Genedrive To Sell Two Divisions For Up To GBP1.9 Million In Cash

LONDON (Alliance News) - Genedrive PLC said Monday it proposed the disposal of the its contract research and pharmacogenomics divisions for up to GBP1.9 million in cash to biotechnology company 2

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.